Effects of omarigliptin on glucose variability and oxidative stress in type 2 diabetes patients: A prospective study-Reference-Cited by-同舟云学术

Effects of omarigliptin on glucose variability and oxidative stress in type 2 diabetes patients: A prospective study

Published:2021-09 Issue: Volume:179 Page:108999
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Ohara Makoto,Nagaike Hiroe,Fujikawa Tomoki,Kohata Yo,Ogawa Maiho,Omachi Takemasa,Sasajima Risa,Chiba Hirotoshi,Ara Toshimasa,Sugawara Ayuka,Hiromura Munenori,Terasaki Michishige,Mori Yusaku,Fukui Tomoyasu,Hirano Tsutomu,Yokoyama Hiroki,Yamagishi Sho-ichi

Funder

Ministry of Education, Culture, Sports, Science and Technology

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference42 articles.

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus;The Diabetes Control and Complications Trial Research Group;N Engl J Med,1993

2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837–53. https://doi.org/10.1016/S0140-6736(98)07019-6

3. The post-prandial state and cardiovascular disease: relevance to diabetes mellitus;Ceriello;Diabetes Metab Res Rev,2000

4. Relationship between daily and day-to-day glycemic variability and increased oxidative stress in type 2 diabetes;Ohara;Diabetes Res Clin Pract,2016

5. Inhibition of DPP-4: a new therapeutic approach for the treatment of type 2 diabetes;Pratley;Curr Med Res Opin,2007

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Omarigliptin, a Novel Once-Weekly Dipeptidyl Peptidase-4 Inhibitor, in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis;Endocrinology and Metabolism;2024-02-29

2. Efficacy and Safety of Omarigliptin, a Novel Once-Weekly Dipeptidyl Peptidase-4 Inhibitor, in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis;Endocrinology and Metabolism;2024-02-29

3. Comparison of Effects of Injectable Semaglutide and Dulaglutide on Oxidative Stress and Glucose Variability in Patients with Type 2 Diabetes Mellitus: A Prospective Preliminary Study;Diabetes Therapy;2023-10-25

4. Antidiabetic omarigliptin dilates rabbit aorta by activating voltage‐dependent K ⁺ channels and the sarco/endoplasmic reticulum Ca ²⁺ ‐ATPase pump;Fundamental & Clinical Pharmacology;2022-09-26

5. Omarigliptin alleviates cognitive dysfunction in Streptozotocin-induced diabetic mouse;Bioengineered;2022-04-01